Navigation Links
Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology

ES versus ReoproR-BMS in the prevention of the cumulative incidence of death, MI, and TVR in acute myocardial infarction patients. The results from MULTI-STRATEGY are anticipated to be presented at a prominent scientific symposium in early 2008.


"These papers highlight the ongoing interest in evaluating new investigational uses of AGGRASTATR in the treatment of high risk cardiovascular disease patients," stated Medicure's President and CEO, Albert D. Friesen, PhD. "We believe AGGRASTATR has significant untapped potential, and look forward to the presentation of new data from studies such as MULTI-STRATEGY in the coming year."


Medicure acquired the exclusive U.S. rights to AGGRASTATR, in August 2006.


Important Information About AGGRASTATR AGGRASTATR was approved by the Food and Drug Administration on May 14, 1998.

AGGRASTATR, in combination with heparin, is indicated for the treatment of acute coronary syndrome, including patients who are to be medically managed and those undergoing percutaneous transluminal coronary angioplasty (PTCA) or atherectomy. In this setting AGGRASTATR has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure. AGGRASTATR has been studied in a setting that included aspirin and heparin.

AGGRASTATR is contraindicated in patients with known hypersensitivity to any component of the product; active internal bleeding or a history of bleeding diathesis within the previous 30 days; or a history of intracranial hemorrhage, intracranial neoplasm, arteriovenous malformation, or aneurysm. Other contraindications to AGGRASTATR include: a history of thrombocytopenia following prior exposure to AGGRASTATR; history of stroke within 30 days or any history of hemorrhagic stroke; major surgical procedure or severe physical trauma within the previous month; history, symptoms, or findings suggestive of aortic dissection. AGG
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Protox Announces Positive Clinical Data from Prostate Cancer Study
4. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
5. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
6. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
7. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
11. Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29
Post Your Comments:
(Date:4/20/2015)... STAMFORD, Conn. , April 20, 2015 /PRNewswire/ ... announced that Alan Butcher has joined ... & Business Development. Alan will have responsibility for ... commercial, near-commercial, and development-stage products that would benefit ... bringing aboard a proven leader," said Purdue President ...
(Date:4/20/2015)... April 20, 2015  U.S. pharmacy cost increases for active ... into the low double-digits by 2016, according to an analysis ... health solutions business of Aon plc (NYSE: ... projected to be 9.5 percent in 2015 and will continue ... predicts a similar rate of increase in 2017, with ...
(Date:4/20/2015)... 2015 Cardinal Innovations Healthcare Solutions ... high-tech, high-touch service delivery, is featuring its highly ... the National Council for Behavioral Health,s annual National ... 20–22, 2015, at the Gaylord Palms Resort and ... , attracts participants from mental health and addiction ...
Breaking Medicine Technology:Purdue Pharma Names J. Alan Butcher Senior Vice President of Licensing & Business Development 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 4Cardinal Innovations Highlights its Managed Care Model During National Council for Behavioral Health's Annual Conference 2Cardinal Innovations Highlights its Managed Care Model During National Council for Behavioral Health's Annual Conference 3
(Date:4/20/2015)... NY (PRWEB) April 21, 2015 ... a 2015 Professional Woman of the Year. Ms. Webb ... healthcare. As the largest, most-recognized networking organization of professional ... profession, the National Association of Professional Women is a ... over 200 local chapters. , “We are like an ...
(Date:4/20/2015)... April 20, 2015 The NFL draft season ... of players to add to their rosters, both for their ... In this episode of SCI TV , Vinnie ... acquisition of Greg Hardy given increased attention on off-field conduct ... year after the Ray Rice scandal brought media scrutiny, once ...
(Date:4/20/2015)... At the famous Avalon Hollywood on April 8th, ... Lounge, with Choices Recovery as the premier sponsor. Organizer ... placement in TV and film, gathered some of the ... goods and services for this daylong event. , ... Celebrity Interview Lounge, speaking with many of the notable ...
(Date:4/20/2015)... Utah (PRWEB) April 20, 2015 Goodreads ... Employer-Provided Health Insurance: Why It’s Good for You and ... , Paul Zane Pilzer and Rick Lindquist have ... Health Insurance: Why It’s Good for You and Your ... nation’s employer health insurance woes - employer-funded individual health ...
(Date:4/20/2015)... Hilo, Hawaii (PRWEB) April 20, 2015 ... , so hurry and secure your space at the start ... 12, 2015, the Olympic-distance race is limited to 500 participants ... Kenoi has already secured his spot). , Now thru April ... $75 for relay team members; after May 1st, the fee ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Suzanne Webb, Chief Executive Officer at Exclusive Surgeries Network, LLC, a 2015 Professional Woman of the Year 2Health News:Character Concerns in the NFL with Vinnie Iyer on SCI TV 2Health News:Choices Recovery South Bend Talks About Healthy Decisions with TV's Adrienne Janic 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 3Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 2Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 3
... PALM BEACH, Fla., Oct. 12 The inaugural Cosmetic ... was called an unqualified success by those that attended. ... the meeting was a great learning opportunity and it ... LLC and its corporate partners. Attendees came from ...
... Noninvasive Medical Technologies, Inc. (NMT), an award-winning company ... pleased to commit its support to the Tim Davis Special ... man teams are currently relay marching over 824 miles across ... plaque with Staff Sgt. Tim Davis, name engraved. U.S. ...
... stem cells are being used to help develop a heart ... researchers have achieved a first step toward growing a living ... mouse embryonic stem cells, Duke University bioengineers performed a series ... develop into heart muscle. , The researchers used a special ...
... ... Inc., innovative provider of one-stop, flat-fee healthcare information technology and support, ... records (EMR) clients through the hiring of new Chief Healthcare Officer ... hosting and billing services to practices and medical groups of all ...
... CHICAGO, Oct. 12 On Tuesday, October 13, in response ... 33 state think tanks will announce their "patient-centered" plan for ... a national study by public policy specialist Art Laffer, will ... on a conference call open to the press (dial-in information ...
... ... receives Active Substance Master File for Cell Sense in vivo imaging agent , ... Pittsburgh, PA (Vocus) October 12, 2009 -- ... for its lead in vivo imaging reagent, Cell Sense CS-1000 (Cell Sense). , ,Celsense filed a ...
Cached Medicine News:Health News:Noninvasive Medical Technologies Supports 824-Mile Tim Davis Special Tactics Memorial March 2Health News:Noninvasive Medical Technologies Supports 824-Mile Tim Davis Special Tactics Memorial March 3Health News:Lab Study Makes Strides in Mending Hearts 2Health News:ITelagen Taps Joel Taylor as Chief Healthcare Officer New Executive to Spearhead EMR Implementations 2Health News:ITelagen Taps Joel Taylor as Chief Healthcare Officer New Executive to Spearhead EMR Implementations 3Health News:The Obamacare Alternative: 33 State Think Tanks Announce Patient-Centered Health Care Reforms 2Health News:Celsense, Inc Files FDA & EMEA Regulatory Submissions 2Health News:Celsense, Inc Files FDA & EMEA Regulatory Submissions 3
... SureFlex™ line of reusable and autoclavable Lithotripsy ... This revolutionary and patented termination method accepts ... In the unlikely event you do manage ... face absolutely prevents damage to your laser ...
ELVeS™ (Endo Laser Vein System) from biolitec is a versatile, easy to use & complete system that allows you to treat all conditions resulting from venous incompetence. (ELVeS has FDA clearance ...
Up-tapered output compresses NA to give low NA fiber performance on high NA fiber stock....
One piece, 100% fused silica construction offers low scatter and high efficiency...
Medicine Products: